Cited by 1,817PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and Cancer

The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Open access

Mendoza, Michelle C., Er, E. Emrah, Blenis, John·2011·Trends in Biochemical Sciences

DOI 10.1016/j.tibs.2011.03.006PMC PMC3112285

Open this paper in CoChat — free account

Abstract

The Ras-extracellular signal-regulated kinase (Ras-ERK) and phosphatidylinositol 3-kinase-mammalian target of rapamycin (PI3K-mTOR) signaling pathways are the chief mechanisms for controlling cell survival, differentiation, proliferation, metabolism, and motility in response to extracellular cues. Components of these pathways were among the first to be discovered when scientists began cloning proto-oncogenes and purifying cellular kinase activities in the 1980s. Ras-ERK and PI3K-mTOR were originally modeled as linear signaling conduits activated by different stimuli, yet even early experiments hinted that they might intersect to regulate each other and co-regulate downstream functions. The extent of this cross-talk and its significance in cancer therapeutics are now becoming clear.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.tibs.2011.03.006

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Serine Phosphorylation of Death Agonist BAD in Response to Survival Factor Results in Binding to 14-3-3 Not BCL-XL
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,578
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,244
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Cell Survival Promoted by the Ras-MAPK Signaling Pathway by Transcription-Dependent and -Independent Mechanisms
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460

Flagged first, then by citations

Show all 103 references

2 of the 103 references couldn’t be matched to a known paper.

Sorted by citations

Items 401–500 of 1,004

Y-Box Binding Protein-1 Promotes Epithelial-Mesenchymal Transition in Sorafenib-Resistant Hepatocellular Carcinoma Cells
Liao, L.-Z., Chen, C.-T., Li, N., Lin, L.-C., Huang, B., Chang, Y.-H., & Chow, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010224 · Cited by 49
Regulation of Tight-Junction Integrity by Insulin in an In Vitro Model of Human Blood–Brain Barrier
Ito, S., Yanai, M., Yamaguchi, S., Couraud, P., & Ohtsuki, S. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.04.036 · Cited by 49
From direct to indirect lithium targets: a comprehensive review of omics data
Roux-Rouquié, M., & Dosseto, A. (2017) · Metallomics · doi:10.1039/c7mt00203c · Cited by 50
Store-Operated Calcium Entry via STIM1 Contributes to MRGPRX2 Induced Mast Cell Functions
Occhiuto, C. J., Kammala, A. K., Yang, C., Nellutla, R., Garcia, M., Gomez, G., & Subramanian, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03143 · Cited by 48
Apo- and holo-lactoferrin stimulate proliferation of mouse crypt cells but through different cellular signaling pathways
Jiang, R., & Lönnerdal, B. L. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.002 · Cited by 49
AKT and the Hallmarks of Cancer
Sementino, E., Hassan, D., Bellacosa, A., & Testa, J. R. (2024) · Cancer Research · doi:10.1158/0008-5472.can-24-1846 · Cited by 54
The Akt inhibitor MK-2206 enhances the cytotoxicity of paclitaxel (Taxol) and cisplatin in ovarian cancer cells
Lin, Y.-H., Chen, B. Y.-H., Lai, W.-T., Wu, S.-F., Guh, J., Cheng, A., & Hsu, L. (2014) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-014-1032-y · Cited by 47
Adaptation and learning of molecular networks as a description of cancer development at the systems-level: Potential use in anti-cancer therapies
Gyurkó, D. M., Veres, D. V., Módos, D., Lenti, K., Korcsmáros, T., & Csermely, P. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.005 · Cited by 50
Synergistic targeted inhibition of MEK and dual PI 3K/ mTOR diminishes viability and inhibits tumor growth of canine melanoma underscoring its utility as a preclinical model for human mucosal melanoma
Wei, B., Michael, H. T., Halsey, C., Peer, C. J., Adhikari, A. S., Dwyer, J. E., Hoover, S. B., Meskini, R. E., Kozlov, S. V., Ohler, Z. W., et al. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12512 · Cited by 47
Activation of Adhesion GPCR EMR2/ADGRE2 Induces Macrophage Differentiation and Inflammatory Responses via Gα16/Akt/MAPK/NF-κB Signaling Pathways
Kuan-Yu, I., Huang, Y.-S., Hu, C.-H., Tseng, W.-Y., Cheng, C.-H., Stacey, M. A., Gordon, S., Chang, G.-W., & Lin, H. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00373 · Cited by 47
MEK inhibitors in oncology: a patent review (2015-Present)
Mahapatra, D. K., Asati, V., & Bharti, S. K. (2017) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2017.1339688 · Cited by 47
Dual inhibition of Akt and ERK signaling induces cell senescence in triple-negative breast cancer
He, Q., Xue, S., Tan, Y., Zhang, L., Shao, Q., Xing, L., Li, Y., Xiang, T., Luo, X., & Ren, G. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.02.004 · Cited by 47
(–)-Epigallocatechin-3-gallate Down-regulates Doxorubicin-induced Overexpression of P-glycoprotein Τhrough the Coordinate Inhibition of PI3K/Akt and MEK/ERK Signaling Pathways
Satonaka, H., Ishida, K., Takai, M., Koide, R., Shigemasa, R., Ueyama, J., Ishikawa, T., Hayashi, K., Goto, H., & Wakusawa, S. (2017) · Anticancer Research · doi:10.21873/anticanres.12055 · Cited by 47
The impact of RASopathy-associated mutations on CNS development in mice and humans
Kang, M., & Lee, Y.-S. (2019) · Molecular Brain · doi:10.1186/s13041-019-0517-5 · Cited by 40
Glycolysis–respiration relationships in a neuroblastoma cell line
Swerdlow, R. H., Lezi, E., Aires, D., & Lu, J. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.01.002 · Cited by 47
Arsenic trioxide potentiates the anti-cancer activities of sorafenib against hepatocellular carcinoma by inhibiting Akt activation
Zhai, B., Jiang, X., He, C., Zhao, D., Ma, L., Xu, L., Jiang, H., & Sun, X. (2014) · Tumor Biology · doi:10.1007/s13277-014-2839-3 · Cited by 46
Emerging targeted therapies for melanoma treatment (Review)
RUSSO, A., Ficili, B., Candido, S., Pezzino, F. M., Guarneri, C., Biondi, A., Travali, S., McCubrey, J. A., Spandidos, D. A., & Libra, M. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2481 · Cited by 47
Involvement of BDNF/ERK signaling in spontaneous recovery from trimethyltin-induced hippocampal neurotoxicity in mice
Lee, S., Yang, M., Kim, J., Son, Y., Kim, J., Kang, S., Ahn, W., Kim, S., Kim, J.-C., Shin, T., et al. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.01.002 · Cited by 46
Exclusive inhibition of PI3K/Akt/mTOR signaling is not sufficient to prevent PDGF-mediated effects on glycolysis and proliferation in colorectal cancer
Moench, R., Grimmig, T., Kannen, V., Tripathi, S., Faber, M., Moll, E.-M., Chandraker, A. K., Lissner, R., Germer, C., Waaga-Gasser, A. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11899 · Cited by 46
Interplay of autophagy, receptor tyrosine kinase signalling and endocytic trafficking
Dudley-Fraser, J., Cabodevilla, A. G., Simpson, J. E., & Gammoh, N. (2017) · Essays in Biochemistry · doi:10.1042/ebc20170091 · Cited by 43
Regulation of Cell-to-Cell Communication and Cell Wall Integrity by a Network of MAP Kinase Pathways and Transcription Factors in Neurospora crassa
Fischer, M. S., Wu, V. W., Lee, J. E., O’Malley, R. C., & Glass, N. L. (2018) · Genetics · doi:10.1534/genetics.118.300904 · Cited by 46
PI3K pathway in prostate cancer: All resistant roads lead to PI3K
Park, S., Kim, Y. S., Kim, D. Y., So, I., & Jeon, J. (2018) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2018.09.001 · Cited by 45
Salt Induces Adipogenesis/Lipogenesis and Inflammatory Adipocytokines Secretion in Adipocytes
Lee, M., Sorn, S. R., Lee, Y., & Kang, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20010160 · Cited by 46
Role of mTORC1 in intestinal epithelial repair and tumorigenesis
Kaur, H., & Moreau, R. F. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03085-6 · Cited by 46
Results from a single arm, single stage phase II trial of trametinib and GSK2141795 in persistent or recurrent cervical cancer
Liu, J. F., Gray, K. P., Wright, A. A., Campos, S. M., Konstantinopoulos, P. A., Peralta, A., MacNeill, K., Morrissey, S., Whalen, C., Dillon, D. A. R., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.05.003 · Cited by 46
LKB1 Deficiency Renders NSCLC Cells Sensitive to ERK Inhibitors
Caiola, E., Iezzi, A., Tomanelli, M., Bonaldi, E., Scagliotti, A., Colombo, M., Guffanti, F., Micotti, E., Garassino, M. C., Minoli, L., et al. (2019) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.10.009 · Cited by 45
Hydrostatic pressure promotes endothelial tube formation through aquaporin 1 and Ras-ERK signaling
Yoshino, D., Funamoto, K., Sato, K., Kenry, K., Sato, M., & Lim, C. T. (2020) · Communications Biology · doi:10.1038/s42003-020-0881-9 · Cited by 46
Suppression of Extracellular Signal-Regulated Kinase Activity in Herpes Simplex Virus 1-Infected Cells by the Us3 Protein Kinase
Chuluunbaatar, U., Roller, R. J., & Mohr, I. (2012) · Journal of Virology · doi:10.1128/jvi.00622-12 · Cited by 46
2D-CuPd nanozyme overcome tamoxifen resistance in breast cancer by regulating the PI3K/AKT/mTOR pathway
Jiang, W., Zhong, S., Chen, Z., Qian, J., Huang, X., Zhang, H., Wen, L., Zhang, Y., & Yao, G. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121986 · Cited by 46
Alternative Signaling Pathways as Potential Therapeutic Targets for Overcoming EGFR and c-Met Inhibitor Resistance in Non-Small Cell Lung Cancer
Fong, J., Jacobs, R. J., Moravec, D. N., Uppada, S. B., Botting, G. M., Nlend, M., & Puri, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078398 · Cited by 45
Dysregulated Translation in Neurodevelopmental Disorders: An Overview of Autism‐Risk Genes Involved in Translation
Chen, Y., Chang, Y., & Huang, Y. (2018) · Developmental Neurobiology · doi:10.1002/dneu.22653 · Cited by 42
IGF-1R inhibition induces MEK phosphorylation to promote survival in colon carcinomas
Wang, Q., Zhang, Y., Zhu, J., Zheng, H., Chen, S., Chen, L., & Yang, H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0204-0 · Cited by 44
Oncogenic viruses and chemoresistance: What do we know?
Nahand, J. S., Rabiei, N., Fathazam, R., Taghizadieh, M., Ebrahimi, M. S., Mahjoubin‐Tehran, M., Baghi, H. B., Khatami, A., Abbasi‐Kolli, M., Mirzaei, H. R., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105730 · Cited by 45
Sustained mTORC1 activity during palbociclib-induced growth arrest triggers senescence in ER+ breast cancer cells
Maskey, R. S., Wang, F., Lehman, E., Wang, Y., Emmanuel, N., Zhong, W., Jin, G., Abraham, R. T., Arndt, K. T., Myers, J. S., et al. (2020) · Cell Cycle · doi:10.1080/15384101.2020.1859195 · Cited by 45
Cooperative induction of apoptosis in NRAS mutant melanoma by inhibition of MEK and ROCK
Vogel, C., Smit, M. A., Maddalo, G., Possik, P. A., Sparidans, R. W., van der Burg, S. H., Verdegaal, E. M. E., Heck, A. J. R., Samatar, A. A., Beijnen, J. H., et al. (2015) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12364 · Cited by 44
Understanding Growth Failure in Costello Syndrome: Increased Resting Energy Expenditure
Leoni, C., Onesimo, R., Giorgio, V., Diamanti, A., Giorgio, D., Martini, L., Rossodivita, A. N., Tartaglia, M., & Zampino, G. (2016) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.11.076 · Cited by 44
Beyond molecular tumor heterogeneity: protein synthesis takes control
y Cajal, S. R., Castellví, J., Hümmer, S., Peg, V., Pelletier, J., & Sonenberg, N. (2018) · Oncogene · doi:10.1038/s41388-018-0152-0 · Cited by 44
Bioactive Compounds from Posidonia oceanica (L.) Delile Impair Malignant Cell Migration through Autophagy Modulation
Leri, M., Ramazzotti, M., Vasarri, M., Peri, S., Barletta, E., Pretti, C., & Degl’Innocenti, D. (2018) · Marine Drugs · doi:10.3390/md16040137 · Cited by 44
Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti‐cancer effect of dasatinib in hepatocellular carcinoma
Sayed, I. E., Helmy, M., & El-Abhar, H. (2018) · Life Science · doi:10.1016/j.lfs.2018.10.002 · Cited by 42
FBXO17 promotes cell proliferation through activation of Akt in lung adenocarcinoma cells
Suber, T. L., Nikolli, I., O’Brien, M. E., Londino, J. D., Zhao, J., Chen, K., Mallampalli, R. K., & Zhao, Y. (2018) · Respiratory Research · doi:10.1186/s12931-018-0910-0 · Cited by 45
Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
Aasen, S. N., Parajuli, H., Hoang, T., Feng, Z., Stokke, K., Wang, J., Roy, K., Bjerkvig, R., Knappskog, S., & Thorsen, F. A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174235 · Cited by 44
The synergistic anti-proliferative effect of the combination of diosmin and BEZ-235 (dactolisib) on the HCT-116 colorectal cancer cell line occurs through inhibition of the PI3K/Akt/mTOR/NF-κB axis
Helmy, M. W., Ghoneim, A. I., Katary, M. A., & Elmahdy, R. K. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05327-4 · Cited by 46
Widespread expression of an exogenous gene in the eye after intravenous administration.
Zhu, C., Zhang, Y., & Pardridge, W. M. (2002) · PubMed · Cited by 44
Molecular design of dual inhibitors of PI3K and potential molecular target of cancer for its treatment: A review
Wang, Y., & Tortorella, M. D. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114039 · Cited by 44
The Fission Yeast Cell Integrity Pathway: A Functional Hub for Cell Survival upon Stress and Beyond
Cansado, J., Soto, T., Franco, A., Vicente‐Soler, J., & Madrid, M. (2021) · Journal of Fungi · doi:10.3390/jof8010032 · Cited by 43
Camphor Induces Proliferative and Anti-senescence Activities in Human Primary Dermal Fibroblasts and Inhibits UV-Induced Wrinkle Formation in Mouse Skin
Tran, T. A., Ho, M. T., Song, Y. W., Cho, M., & Cho, S. K. (2015) · Phytotherapy Research · doi:10.1002/ptr.5484 · Cited by 45
Influence of node abundance on signaling network state and dynamics analyzed by mass cytometry
Lun, X., Zanotelli, V. R., Wade, J. D., Schapiro, D., Tognetti, M., Dobberstein, N., & Bodenmiller, B. (2017) · Nature Biotechnology · doi:10.1038/nbt.3770 · Cited by 41
Ganoderma triterpenes retard renal cyst development by downregulating Ras/MAPK signaling and promoting cell differentiation
Su, L., Liu, L., Jia, Y., Lei, L., Liu, J., Zhu, S., Zhou, H., Chen, R.-Y., Lu, H., & Yang, B. (2017) · Kidney International · doi:10.1016/j.kint.2017.04.013 · Cited by 43
Inclusion complex of saikosaponin-d with hydroxypropyl-β-cyclodextrin: Improved physicochemical properties and anti-skin cancer activity
Hu, S. C., Lai, Y.-C., Lin, C., Tzeng, W., & Yen, F. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.11.012 · Cited by 43
Is Structure-Based Drug Design Ready for Selectivity Optimization?
Albanese, S. K., Chodera, J. D., Volkamer, A., Keng, S., Abel, R., & Wang, L. (2020) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c00815 · Cited by 44
Manuka honey enhanced sensitivity of HepG2, hepatocellular carcinoma cells, for Doxorubicin and induced apoptosis through inhibition of Wnt/β-catenin and ERK1/2
Alrefaey, H. R., Newairy, A. A., Wahby, M. M., Albanese, C., Elkewedi, M., Choudhry, M. U., & Sultan, A. S. (2021) · Biological Research · doi:10.1186/s40659-021-00339-1 · Cited by 43
Current Perspectives and Novel Strategies of NRAS-Mutant Melanoma
García‐Álvarez, A., Ortiz, C., & Muñoz‐Couselo, E. (2021) · OncoTargets and Therapy · doi:10.2147/ott.s278095 · Cited by 46
Cell type-dependent Erk-Akt pathway crosstalk regulates the proliferation of fetal neural progenitor cells
Rhim, J. H., Luo, X., Gao, D., Xu, X., Zhou, T., Li, F., Wang, P., Wong, S. T. C., & Xia, X. (2016) · Scientific Reports · doi:10.1038/srep26547 · Cited by 42
Gene knockdown of CCR3 reduces eosinophilic inflammation and the Th2 immune response by inhibiting the PI3K/AKT pathway in allergic rhinitis mice
Yuan, J., Liu, Y., Yu, J., Dai, M., Zhu, Y. T., Bao, Y., Peng, H., Liu, K., & Zhu, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-09467-4 · Cited by 42
The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
Huang, S. Q., Liao, X., Wu, J., Zhang, X., Li, Y., Xiang, D., & Luo, S. (2022) · FEBS Letters · doi:10.1002/1873-3468.14336 · Cited by 42
Sesquiterpene Lactones as Promising Candidates for Cancer Therapy: Focus on Pancreatic Cancer
Laurella, L. C., Mirakian, N. T., Garcia, M. N., Grasso, D., Sülsen, V. P., & Papademetrio, D. L. (2022) · Molecules · doi:10.3390/molecules27113492 · Cited by 41
Role of kidney biomarkers of chronic kidney disease: An update
Khan, Z., & Pandey, M. (2014) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.07.003 · Cited by 42
In vitro study of combined cilengitide and radiation treatment in breast cancer cell lines
Lautenschlaeger, T., Perry, J., Peereboom, D. M., Li, B., Ibrahim, A., Hüebner, A., Meng, W., White, J. R., & Chakravarti, A. (2013) · Radiation Oncology · doi:10.1186/1748-717x-8-246 · Cited by 43
Principles of K-Ras effector organization and the role of oncogenic K-Ras in cancer initiation through G1 cell cycle deregulation
Nussinov, R., Tsai, C., Muratcioğlu, S., Jang, H., Gürsoy, A., & Keskin, Ö. (2015) · Expert Review of Proteomics · doi:10.1586/14789450.2015.1100079 · Cited by 42
Overexpression of miR-335 confers cell proliferation and tumour growth to colorectal carcinoma cells
Lu, Y., Yang, H., Li, Y., Liu, G., Zhang, C., Hong, M., Liu, Y., Zhou, M., Chen, F., & Li, X. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2630-9 · Cited by 42
Vertical Targeting of AKT and mTOR as Well as Dual Targeting of AKT and MEK Signaling Is Synergistic in Hepatocellular Carcinoma
Ewald, F., Nörz, D. S., Grottke, A., Bach, J., Herzberger, C., Hofmann, B. T., Nashan, B., & Jücker, M. (2015) · Journal of Cancer · doi:10.7150/jca.12452 · Cited by 43
PP242 Counteracts Glioblastoma Cell Proliferation, Migration, Invasiveness and Stemness Properties by Inhibiting mTORC2/AKT
Mecca, C., Giambanco, I., Bruscoli, S., Bereshchenko, O., Fioretti, B., Riccardi, C., Donato, R., & Arcuri, C. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00099 · Cited by 43
CellCycleTRACER accounts for cell cycle and volume in mass cytometry data
Rapsomaniki, M., Lun, X., Woerner, S., Laumanns, M., Bodenmiller, B., & Martínez, M. R. (2018) · Nature Communications · doi:10.1038/s41467-018-03005-5 · Cited by 40
The Specificity of EGF-Stimulated IQGAP1 Scaffold Towards the PI3K-Akt Pathway is Defined by the IQ3 motif
Chen, M., Choi, S., Jung, O., Wen, T., Baum, C., Thapa, N., Lambert, P. F., Rapraeger, A. C., & Anderson, R. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-45671-5 · Cited by 42
Safety lead-in of the MEK inhibitor trametinib in combination with GSK2141795, an AKT inhibitor, in patients with recurrent endometrial cancer: An NRG Oncology/GOG study
Westin, S. N., Sill, M. W., Coleman, R. L., Waggoner, S. E., Moore, K. N., Mathews, C. A., Martin, L. P., Modesitt, S. C., Lee, S., Ju, Z., et al. (2019) · Gynecologic Oncology · doi:10.1016/j.ygyno.2019.09.024 · Cited by 42
Metformin attenuates the D‑galactose‑induced aging process via the UPR through the AMPK/ERK1/2 signaling pathways
Cai, H. “., Han, B., Hu, Y., Zhao, X., He, Z., Chen, X., Sun, H., Yuan, J., Li, Y., Yang, X., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4453 · Cited by 43
A Phase I Study of Dinaciclib in Combination With MK‐2206 in Patients With Advanced Pancreatic Cancer
Murphy, A. G., ZAHURAK, M. L., Shah, M., Weekes, C. D., Hansen, A. R., Siu, L. L., Spreafico, A., LoConte, N. K., Anders, N. M., Miles, T., et al. (2020) · Clinical and Translational Science · doi:10.1111/cts.12802 · Cited by 42
ANXA6 suppresses the tumorigenesis of cervical cancer through autophagy induction
Sun, X., Shu, Y., Xu, M., Jiang, J.-K., Wang, L., Wang, J., Huang, D., & Zhang, J. (2020) · Clinical and Translational Medicine · doi:10.1002/ctm2.208 · Cited by 41
SYK inhibition targets acute myeloid leukemia stem cells by blocking their oxidative metabolism
Polak, A., Białopiotrowicz, E., Krzymieniewska, B., Woźniak, J., Stojak, M., Cybulska, M., Kaniuga, E., Mikuła, M., Jabłońska, E., Górniak, P., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03156-8 · Cited by 42
CB2 receptor activation inhibits the phagocytic function of microglia through activating ERK/AKT-Nurr1 signal pathways
Han, Q.-W., Shao, Q.-H., Wang, X., Ma, K., Chen, N., & Yuan, Y. (2022) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00853-8 · Cited by 40
Investigating the NRAS 5' UTR as a Target for Small Molecules
Balaratnam, S., Torrey, Z. R., Calabrese, D. R., Banco, M. T., Yazdani, K., Xiao, L., Fullenkamp, C. R., Seshadri, S., Holewinski, R. J., Andrésson, Þ., et al. (2022) · Cell chemical biology · doi:10.1016/j.chembiol.2023.05.004 · Cited by 42
PTEN signaling through RAF1 proto-oncogene serine/threonine kinase (RAF1)/ERK in the epididymis is essential for male fertility
Xu, B., Washington, A. M., & Hinton, B. T. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413186112 · Cited by 41
mTORC1 upregulation via ERK-dependent gene expression change confers intrinsic resistance to MEK inhibitors in oncogenic KRas-mutant cancer cells
Komatsu, N., Fujita, Y., Matsuda, M., & Aoki, K. (2015) · Oncogene · doi:10.1038/onc.2015.16 · Cited by 43
Mitogen-Activated Protein Kinase-Interacting Kinase Regulates mTOR/AKT Signaling and Controls the Serine/Arginine-Rich Protein Kinase-Responsive Type 1 Internal Ribosome Entry Site-Mediated Translation and Viral Oncolysis
Brown, M. C., Dobrikov, M. I., & Gromeier, M. (2014) · Journal of Virology · doi:10.1128/jvi.01884-14 · Cited by 40
Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway
Bommer, U., Iadevaia, V., Chen, J., Knoch, B., Engel, M., & Proud, C. G. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.04.011 · Cited by 42
The components of Huang-Lian-Jie-Du-Decoction act synergistically to exert protective effects in a rat ischemic stroke model
Zhang, Q., Wang, J., Zhang, C., Liao, S., Li, P., Xu, D., Lv, Y., Yang, M., & Kong, L. (2016) · Oncotarget · doi:10.18632/oncotarget.12645 · Cited by 41
Citrulline directly modulates muscle protein synthesis via the PI3K/MAPK/4E-BP1 pathway in a malnourished state: evidence from in vivo, ex vivo, and in vitro studies
Plénier, S. L., Goron, A., Sotiropoulos, A., Archambault, E., Guihenneuc‐Jouyaux, C., Walrand, S., Salles, J., Jourdan, M., Neveux, N., Cynober, L., et al. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00203.2016 · Cited by 47
AQP9-induced cell cycle arrest is associated with RAS activation and improves chemotherapy treatment efficacy in colorectal cancer
Huang, D., Feng, X., Liu, Y., Deng, Y., Chen, H., Chen, D., Fang, L., Cai, Y., Liu, H., Wang, L., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.282 · Cited by 41
Atorvastatin downregulates co-inhibitory receptor expression by targeting Ras-activated mTOR signalling
Okoye, I., Namdar, A., Xu, L., Crux, N. B., & Elahi, S. (2017) · Oncotarget · doi:10.18632/oncotarget.21003 · Cited by 41
Messages from the voices within: regulation of signaling by proteins of the nuclear lamina
Gerace, L., & Tapia, O. (2018) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.12.009 · Cited by 42
A miR-29b Byproduct Sequence Exhibits Potent Tumor-Suppressive Activities via Inhibition of NF-κB Signaling in KRAS -Mutant Colon Cancer Cells
Inoue, A., Mizushima, T., Wu, X., Okuzaki, D., Kambara, N., Ishikawa, S., Wang, J., Qian, Y., Hirose, H., Yokoyama, Y., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0850 · Cited by 41
Scutellaria baicalensis targets the hypoxia‐inducible factor‐1α and enhances cisplatin efficacy in ovarian cancer
Hussain, I., Waheed, S., Ahmad, K. A., Pirog, J. E., & Syed, V. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27063 · Cited by 41
M1 muscarinic receptors regulate the phosphorylation of AMPA receptor subunit GluA1 via a signaling pathway linking cAMP‐PKA and PI3K‐Akt
Zhao, L., Ge, Y., Li, J., Xiong, C., Law, P., Xu, J., Qiu, Y. L., & Chen, H. (2019) · The FASEB Journal · doi:10.1096/fj.201802351r · Cited by 41
Predicting ligand-dependent tumors from multi-dimensional signaling features
Hass, H., Masson, K., Wohlgemuth, S., Paragas, V. B., Allen, J. E., Sevecka, M., Pace, E. A., Timmer, J., Stelling, J., MacBeath, G., et al. (2017) · npj Systems Biology and Applications · doi:10.1038/s41540-017-0030-3 · Cited by 43
Gene networks that compensate for crosstalk with crosstalk
Müller, I. E., Rubens, J. R., Jun, T. W., Graham, D. B., Xavier, R. J., & Lu, T. K. (2019) · Nature Communications · doi:10.1038/s41467-019-12021-y · Cited by 40
FGFR-inhibitor-mediated dismissal of SWI/SNF complexes from YAP-dependent enhancers induces adaptive therapeutic resistance
Li, Y., Qiu, X., Wang, X., Liu, H., Geck, R. C., Tewari, A. K., Xiao, T., Font‐Tello, A., Lim, K., Jones, K. L., et al. (2021) · Nature Cell Biology · doi:10.1038/s41556-021-00781-z · Cited by 41
MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1
Brundage, M. E., Tandon, P., Eaves, D. W., Williams, J. P., Miller, S. J., Hennigan, R. F., Jegga, A. G., Cripe, T. P., & Ratner, N. (2014) · Oncogene · doi:10.1038/onc.2013.506 · Cited by 41
Megalencephalic leukoencephalopathy with subcortical cysts protein-1 regulates epidermal growth factor receptor signaling in astrocytes
Lanciotti, A., Brignone, M. S., Visentin, S., Nuccio, C. D., Catacuzzeno, L., Mallozzi, C., Petrini, S., Caramia, M., Veroni, C., Minnone, G., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw032 · Cited by 41
Aflatoxin B1 disrupts testicular development via the cell cycle-related Ras/PI3K/Akt signaling in mice and pig
Zhang, F., Ma, H., Dong, P.-Y., Yuan, Z.-N., Zhang, S.-E., Zhao, A.-H., Liu, H., Felici, M. D., Shen, W., & Zhang, X. (2023) · Environmental Pollution · doi:10.1016/j.envpol.2023.121729 · Cited by 40
Neurodevelopmental disorders and cancer networks share pathways, but differ in mechanisms, signaling strength, and outcome
Yavuz, B. R., Arici, M. K., Demirel, H. C., Tsai, C., Jang, H., Nussinov, R., & Tunçbağ, N. (2023) · npj Genomic Medicine · doi:10.1038/s41525-023-00377-6 · Cited by 41
Signal transduction pathways activated by insulin‐like peptide 5 at the relaxin family peptide RXFP4 receptor
Ang, S. Y., Hutchinson, D. S., Patil, N. A., Evans, B. A., Bathgate, R. A. D., Halls, M. L., Hossain, M. A., Summers, R. J., & Kočan, M. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13522 · Cited by 38
Effect of miR‐182 on hepatic fibrosis induced by Schistosomiasis japonica by targeting FOXO1 through PI3K / AKT signaling pathway
Huang, Y., Fan, X., Tao, R., Song, Q., Wang, L., Zhang, H., Kong, H., & Huang, J. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26469 · Cited by 40
Multiple growth factor delivery for skin tissue engineering applications
Park, U., & Kim, K. (2017) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-017-0436-1 · Cited by 40
Quantitative Measurement of Functional Activity of the PI3K Signaling Pathway in Cancer
van de Stolpe, A. (2019) · Cancers · doi:10.3390/cancers11030293 · Cited by 39
16S rRNA gene sequencing reveals the relationship between gut microbiota and ovarian development in the swimming crab Portunus trituberculatus
Wei, H., Li, X., Tang, L., Yao, H., Ren, Z., Wang, C., Mu, C., Shi, C., & Wang, H. (2020) · Chemosphere · doi:10.1016/j.chemosphere.2020.126891 · Cited by 40
A POETIC Phase II study of continuous oral everolimus in recurrent, radiographically progressive pediatric low‐grade glioma
Wright, K. D., Yao, X., London, W. B., Kao, P., Gore, L., Hunger, S. P., Geyer, R., Cohen, K. J., Allen, J. C., Katzenstein, H. M., et al. (2020) · Pediatric Blood & Cancer · doi:10.1002/pbc.28787 · Cited by 41
A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemia
Damnernsawad, A., Bottomly, D., Kurtz, S. E., Eide, C. A., McWeeney, S. K., Tyner, J. W., & Nechiporuk, T. (2020) · Haematologica · doi:10.3324/haematol.2020.257964 · Cited by 40
LY3214996 relieves acquired resistance to sorafenib in hepatocellular carcinoma cells
Ma, Y., Xu, R., Liu, X., Zhang, Y., Li, S., Qiu, X., Cai, S., Zhou, S., Xie, Y., Li, A., et al. (2021) · International Journal of Medical Sciences · doi:10.7150/ijms.51256 · Cited by 39
Cellular pharmacodynamics of a novel pyrrolo[3,2-d]pyrimidine inhibitor targeting mitochondrial and cytosolic one-carbon metabolism
Dekhne, A. S., Ning, C., Nayeen, M. J., Shah, K., Kalpage, H., Frühauf, J., Wallace-Povirk, A., O’Connor, C., Hou, Z., Kim, S., et al. (2020) · Molecular Pharmacology · doi:10.1124/mol.119.117937 · Cited by 40
Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality
Zhang, W., Xia, D., Li, Z., Zhou, T., Chen, T., Wu, Z., Zhou, W., Li, Z., Li, L., & Xu, J. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1855-z · Cited by 38

Authors: Mendoza, M. C., Er, E. E., & Blenis, J.
Affiliations: Harvard University (US)
Corresponding author: Blenis, John
ORCID: Mendoza, Michelle C.
Er, E. Emrah
Blenis, John
Venue: Trends in Biochemical Sciences
Publisher: Elsevier BV
Published: 2011-06
Volume: 36
Issue: 6
Pages: 320-328
ISSN: 0968-0004 (ISSN-L)
DOI: 10.1016/j.tibs.2011.03.006
PMC: PMC3112285
OpenAlex: W1998203489
Cited by: 1,817
References: 103
Citations by year: 2026: 112 · 2025: 96 · 2024: 122 · 2023: 133 · 2022: 127 · 2021: 163 · 2020: 166 · 2019: 164 · 2018: 144 · 2017: 158 · 2016: 123 · 2015: 100 · 2014: 92 · 2013: 55 · 2012: 49
FWCI: 5.82
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Biochemical Sciences (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: LAM Foundation
Susan G. Komen
National Cancer Institute (R37CA046595)
National Institute of General Medical Sciences (R01GM051405)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Keywords: Ras/ERK signaling pathway, signaling crosstalk, cell survival, cell proliferation, cell differentiation, cellular metabolism, cell motility, proto-oncogenes, cancer therapeutics
MeSH terms: Humans, Signal Transduction, ras Proteins, Extracellular Signal-Regulated MAP Kinases, Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks